Immuron Limited (IMRN:NASDAQ) closed at $0.900 on November 10, 2026, up 2.27% on the day. The stock trades 54.8% below its 52-week high of $1.99 and 32.9% above its 52-week low of $0.677. Over the past year, it lost 45.3%. Immuron Limited is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 10, 2025, IMRN closed higher on 100 days (40%). Its best day was September 4, 2026 (+62.16%) and its worst was December 10, 2025 (-25.83%). The stock moved 10% or more in a single session 18 times. It opened at least 5% above the previous day's high 2 times.
Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.
Find more stocks like IMRN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.